Figure 1.
Mean (±s.d.) saquinavir steady state plasma concentration-time profile following administration of SQV-SGC 1200 mg three times daily (Treatment B, ○) or SQV-SGC 1200 mg three times daily plus rifabutin 300 mg once daily (Treatment C, □).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.